Cargando…

Editorial: Hallmark of cancer: Reprogramming of cellular metabolism

Detalles Bibliográficos
Autores principales:	Kaur, Baljinder, Sohrabi, Yahya, Achreja, Abhinav, Lisanti, Michael P., Martinez-Outschoorn, Ubaldo Emilio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874241/ https://www.ncbi.nlm.nih.gov/pubmed/36713555 http://dx.doi.org/10.3389/fonc.2022.1126913

Ejemplares similares

Editorial: Cancer Ecosystems
por: Martinez-Outschoorn, Ubaldo E., et al.
Publicado: (2019)

Editorial: Hallmark of cancer: replicative immortality
por: Bailey, Susan M.
Publicado: (2023)

Editorial: Metabolic reprogramming in breast cancer
por: Scatena, Cristian, et al.
Publicado: (2022)

Editorial: Hallmark of cancer: Resisting cell death
por: Zhu, Yichao, et al.
Publicado: (2022)

Editorial: Hallmark of cancer: avoiding immune suppression
por: Alenzi, Faris Q. B., et al.
Publicado: (2023)

Editorial: Hallmark of cancer: Evasion of growth suppressors
por: Scheel, Christina H., et al.
Publicado: (2023)

Editorial: Hallmark of cancer: tumor promoting inflammation
por: Roncati, Luca, et al.
Publicado: (2023)

Editorial: Cell Stress, Metabolic Reprogramming, and Cancer
por: Giannattasio, Sergio, et al.
Publicado: (2018)

Editorial: Oncogenic RAS-Dependent Reprogramming of Cellular Plasticity
por: Konstantinidou, Georgia, et al.
Publicado: (2020)

Cancer Metabolism: New Validated Targets for Drug Discovery
por: Sotgia, Federica, et al.
Publicado: (2013)

Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Editorial: Exploring Cancer Metabolic Reprogramming through Molecular Imaging
por: Podo, Franca, et al.
Publicado: (2017)

Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma
por: Hsu, Tsung-I
Publicado: (2023)

Hallmarks of Metabolic Reprogramming and Their Role in Viral Pathogenesis
por: Allen, Charles N. S., et al.
Publicado: (2022)

An Update to Hallmarks of Cancer
por: Ravi, Swapna, et al.
Publicado: (2022)

Remodeling of mitochondrial morphology and function: an emerging hallmark of cellular reprogramming
por: Rastogi, Anuj, et al.
Publicado: (2019)

Cancer stem cell metabolism
por: Peiris-Pagès, Maria, et al.
Publicado: (2016)

Reprogrammed Lipid Metabolism and the Lipid-Associated Hallmarks of Colorectal Cancer
por: Salita, Timothy, et al.
Publicado: (2022)

Editorial: Proteomic and metabolic reprogramming in myeloma cells within the tumor microenvironment
por: Milan, Enrico, et al.
Publicado: (2023)

Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling
por: Zanoni, Michele, et al.
Publicado: (2023)

Metabolic Pathways and Targets in Chondrosarcoma
por: Micaily, Ida, et al.
Publicado: (2021)

Immunometabolic reprogramming, another cancer hallmark
por: Kumar, Vijay, et al.
Publicado: (2023)

Fructose 2,6-Bisphosphate in Cancer Cell Metabolism
por: Bartrons, Ramon, et al.
Publicado: (2018)

STAT3-Mediated Metabolic Reprograming in Cellular Transformation and Implications for Drug Resistance
por: Poli, Valeria, et al.
Publicado: (2015)

Editorial: Cancer cell reprogramming: Impact on carcinogenesis and cancer progression
por: Zhao, Yue, et al.
Publicado: (2023)

Editorial: Linking cellular metabolism to hematological malignancies
por: He, Xiujing, et al.
Publicado: (2022)

Is angiogenesis a hallmark of prostate cancer?
por: Taverna, Gianluigi, et al.
Publicado: (2013)

Metabostemness: A New Cancer Hallmark
por: Menendez, Javier A., et al.
Publicado: (2014)

Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention?
por: Sotgia, Federica, et al.
Publicado: (2011)

Metabolic remodeling of the tumor microenvironment: Migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth
por: Carito, Valentina, et al.
Publicado: (2012)

Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming
por: D'Alessandro, Angelo, et al.
Publicado: (2018)

Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)

Lipid metabolism reprogramming in head and neck cancer
por: Liang, Jinfeng, et al.
Publicado: (2023)

Editorial: Cellular and Phenotypic Plasticity in Cancer
por: Ferrao, Petranel T., et al.
Publicado: (2015)

Lactylation, an emerging hallmark of metabolic reprogramming: Current progress and open challenges
por: Liu, Xuelian, et al.
Publicado: (2022)

The Relationship of Redox With Hallmarks of Cancer: The Importance of Homeostasis and Context
por: Xing, Faliang, et al.
Publicado: (2022)

Tumor acidity: From hallmark of cancer to target of treatment
por: Bogdanov, Alexey, et al.
Publicado: (2022)

Hallmarks of cancer: The insulin-like growth factors perspective
por: Werner, Haim, et al.
Publicado: (2022)

Platelets in the tumor microenvironment and their biological effects on cancer hallmarks
por: Chen, Lilan, et al.
Publicado: (2023)

Genetic Induction of the Warburg Effect Inhibits Tumor Growth
por: Sotgia, Federica, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_agek4qa7f8n24qf6l9rgcre0dl